Accelerant Holdings Dossier
|
SectorFinancials IndustryInsurance Brokers Beta (adjusted)1.00 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $19.73Price as of 30 Sep 2026 Data confidence Sign in to view data confidence Market Cap $4.3B Enterprise Value $2.8B Shares Outstanding 205.4M diluted Next Earnings Date10 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Accelerant Holdings (NYSE: ARX) is successfully executing a structural shift toward a capital-light, fee-centric risk exchange platform. By connecting specialty insurance underwriters (MGAs) with institutional risk capital partners through its proprietary InsightFull technology, the company generates highly recurring, high-margin fee revenue while avoiding traditional balance sheet underwriting risk. Despite a massive GAAP net loss in 2025 driven by a one-time, non-cash IPO-related profits interest distribution, the underlying cash economics are exceptionally strong, with Adjusted EBITDA growing 149% in 2025 and Q1 2026 fee-based revenue rising 52% year-over-year. The recent appointment of veteran public company CFO Linda Huber and a newly authorized $200 million share repurchase program provide strong operational and capital allocation backstops, making the stock highly attractive at current valuation levels. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$16.00 Mean target$21.10 High · most bullish analyst$30.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario A severe downturn in the specialty insurance pricing cycle or increased competition from traditional fronting carriers slows MGA member growth. Institutional capital partners pull back capacity due to macroeconomic volatility, forcing Accelerant to retain more risk on its own balance sheet. Underwriting quality slips, causing the gross loss ratio to rise above 55%, which damages partner trust and compresses fee margins. Adjusted EBITDA falls short of guidance, coming in below $250 million, keeping the stock range-bound. Base CaseCentral scenario The company continues to scale its Risk Exchange platform, expanding its member base of MGAs and attracting diversified institutional capital. Third-party direct written premium rises to represent over 45% of total exchange volume, driving fee-based Adjusted EBITDA to meet or exceed the full-year 2026 guidance of $285 million. Underwriting discipline remains intact with the gross loss ratio anchored near 51-52%. Valuation multiples expand as the market fully digests the non-cash nature of the 2025 GAAP loss and recognizes the high-margin, recurring fee stream. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |